Neutrophils in cisplatin AKI-mediator or marker?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28646989.
- Also identified by DOI 10.1016/j.kint.2017.03.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inflammation is an important mediator of most forms of acute kidney injury (AKI). Although neutrophils are prominent components of the inflammatory cascade, the precise role of neutrophils in AKI and the mechanisms by which they contribute to AKI remain controversial. In this issue, Deng et al. identify an important cross talk between renal epithelial cells and neutrophils involving the production and action of leukotriene B4 in mediating cisplatin AKI. We discuss the possible explanations for the discrepant findings that have been reported for neutrophils in cisplatin AKI.
Medical subject headings
- Cisplatin
- Neutrophils